首页> Journal of clinical medicine> KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.

KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.

导出 LinkOut

翻译打印收藏纠错

第一作者： Fatih,Atalah

第一单位： Department of Medical Oncology, Faculty of Medicine, Istanbul Medeniyet University, 34956 Istanbul, Turkey.

作者： Fatih,Atalah ^[1] ; Fatih,Kuş ^[2] ; Aydın,Acarbay ^[1] ; Akgün,Karakök ^[1] ; Onur,Alkan ^[1] ; İsmail,Nazlı ^[1] ; Utku,Özilice ^[3] ; Mehmet,Beşiroğlu ^[1] ; Mahmut,Gümüş ^[1]

作者单位： Department of Medical Oncology, Faculty of Medicine, Istanbul Medeniyet University, 34956 Istanbul, Turkey. ^[1] Ankara Atatürk Sanatorium Training and Research Hospital, 06290 Ankara, Turkey. ^[2] Department of Internal Medicine, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07425 Alanya, Turkey. ^[3]

关键词 ARPI KELIM PSA PSA kinetics castration-resistant prostate cancer prognosis prostate cancer

DOI 10.3390/jcm14228114

PMID 41303148

发布时间 2025-11-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2025年14卷22期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of clinical medicine

2025年14卷22期

检索历史清除

KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.

Journal of clinical medicine

相似文献

同项目论文

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.

Journal of clinical medicine

相似文献

同项目论文

Journal of clinical medicine

相关期刊

检索历史清除